Sunday, October 01, 2006

1.6 Million Americans Use CAM for Insomnia or Trouble Sleeping

A recent analysis of national survey data reveals that over 1.6 million American adults use some form of complementary and alternative medicine (CAM) to treat insomnia or trouble sleeping according to scientists at the National Center for Complementary and Alternative Medicine (NCCAM), part of the National Institutes of Health. The data came from the 2002 National Health Interview Survey (NHIS) conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention. In 2002 the NHIS, an in-person, annual health survey, included over 31,000 U.S. adults aged 18 years and older. A CAM supplement to the survey asked about the use of 27 types of CAM therapies, as well as a variety of medical conditions for which CAM may be used, including insomnia or trouble sleeping.

Read More

Monday, September 18, 2006

Poll: 57% Adults Suffer from Insomnia in China

A poll done in six cities in China shows that 57% of adults suffer from insomnia over the past year, and 53% say that they have suffered from this problem for more than one year. However, only 13% patients tell their doctors about their sleeping condition. Many of them, even if they have some sleeping problem, dont mention it in front of the doctor, and for most of the time, doctors don't ask them about it. It is said that insomnia is linked with many diseases, and these diseases will make the problem even worse. However, most doctors pay little attention to insomnia problem. In light of this, Fan Dongshen, vice president of the Peking University No.3 Hospital urge doctors to raise the question with their patients. Five years ago, the China Medical Association conducted an investigation about Chinese people's sleeping condition.

Read More

Sunday, September 10, 2006

NovaDel initiates clinical trial for insomnia spray

NovaDel Pharma has initiated a clinical trial of its proprietary formulation of zolpidem oral spray that will be key to the company's new drug application for the insomnia drug candidate. Zolpidem is the active ingredient found in the number one selling hypnotic, Ambien (zolpidem tartrate), which is marketed by Sanofi-Aventis. The trial, which is being conducted in healthy human volunteers, is designed to evaluate the pharmacokinetic profile of NovaDel's oral spray versus the 10mg Ambien tablet.

Read More

Saturday, September 02, 2006

For Insomnia, Acupressure Tapping Technique May Out-Perform Drugs ...

Six weeks of cognitive therapy treats insomnia better than prescription drugs, but EFT, a do-it-yourself acupressure tapping technique, may out-perform both -- and its results are both fast and lasting. San Francisco CA (PRWEB) August 31, 2006 -- More than 82 million Americans have trouble falling asleep and staying asleep. Insomnia does more than put people in a grumpy mood; it contributes to errors and accidents in the workplace, disrupts hormone balance, accelerates the aging process, and is considered a risk factor for depression, diabetes, obesity, cancer, and other illnesses. Prescription and over-the-counter sleep aids are among our most popular drugs, but drugs don't always work and often have adverse side effects. One answer is cognitive behavioral therapy, which has been shown to treat chronic insomnia better than a prescription drug.

Read More